| http://dbpedia.org/ontology/abstract
|
Neurocrine Biosciences, Inc. is an America … Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD). The company is also developing treatments that are in various stages of clinical research for Parkinson's disease, Tourette syndrome, and congenital adrenal hyperplasia and with a partner for endometriosis and uterine fibroids.er for endometriosis and uterine fibroids.
|
| http://dbpedia.org/ontology/foundingYear
|
1992
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/William_Rastetter +
, http://dbpedia.org/resource/Chief_executive_officer +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/San_Diego%2C_California +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
400
|
| http://dbpedia.org/ontology/revenue
|
7.88E8
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Neurocrine-logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.neurocrine.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
5249173
|
| http://dbpedia.org/ontology/wikiPageLength
|
14592
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1051480711
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/AbbVie_Inc. +
, http://dbpedia.org/resource/Opicapone +
, http://dbpedia.org/resource/Bial +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Lawrence_Steinman +
, http://dbpedia.org/resource/Abbott_Laboratories +
, http://dbpedia.org/resource/Pfizer +
, http://dbpedia.org/resource/Approvable_letter +
, http://dbpedia.org/resource/Corticotropin-releasing_hormone +
, http://dbpedia.org/resource/Initial_public_offering +
, http://dbpedia.org/resource/New_drug_application +
, http://dbpedia.org/resource/Eli_Lilly_and_Company +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Uterine_fibroid +
, http://dbpedia.org/resource/Valbenazine +
, http://dbpedia.org/resource/Biopharmaceutical +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/S&P_400 +
, http://dbpedia.org/resource/Parkinson%27s_disease +
, http://dbpedia.org/resource/Tardive_dyskinesia +
, http://dbpedia.org/resource/William_Rastetter +
, http://dbpedia.org/resource/NASDAQ +
, http://dbpedia.org/resource/Salk_Institute_for_Biological_Studies +
, http://dbpedia.org/resource/San_Diego%2C_California +
, http://dbpedia.org/resource/Wylie_Vale +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1992 +
, http://dbpedia.org/resource/Gonadotropin-releasing_hormone_antagonist +
, http://dbpedia.org/resource/Endometriosis +
, http://dbpedia.org/resource/File:Neurocrine-logo.PNG +
, http://dbpedia.org/resource/Non-approvable_letter +
, http://dbpedia.org/resource/Janssen_Pharmaceutica +
, http://dbpedia.org/resource/Insomnia +
, http://dbpedia.org/resource/Stanford_University +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
, http://dbpedia.org/resource/Elagolix +
, http://dbpedia.org/resource/Indiplon +
, http://dbpedia.org/resource/Tourette_syndrome +
, http://dbpedia.org/resource/Catechol-O-methyl_transferase +
, http://dbpedia.org/resource/Russell_1000 +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Category:1995_initial_public_offerings +
, http://dbpedia.org/resource/Orphan_drug +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Congenital_adrenal_hyperplasia +
|
| http://dbpedia.org/property/founded
|
1992
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Kevin C. Gorman, CEO
, William Rastetter, Chairman
|
| http://dbpedia.org/property/location
|
San Diego, California, U.S.
|
| http://dbpedia.org/property/logo
|
220
|
| http://dbpedia.org/property/name
|
Neurocrine Biosciences, Inc.
|
| http://dbpedia.org/property/numEmployees
|
400
|
| http://dbpedia.org/property/revenue
|
7.88E8
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Ubl +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Url +
|
| http://dbpedia.org/property/wordnet type
|
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:1995_initial_public_offerings +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1992 +
, http://dbpedia.org/resource/Category:Companies_based_in_San_Diego +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.429755.8 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Neurocrine_Biosciences?oldid=1051480711&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Neurocrine-logo.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Neurocrine_Biosciences +
|
| http://xmlns.com/foaf/0.1/name
|
Neurocrine Biosciences, Inc.
|
| owl:sameAs |
http://sw.cyc.com/concept/Mx4rvmyhiJwpEbGdrcN5Y29ycA +
, http://rdf.freebase.com/ns/m.0d9x5t +
, http://dbpedia.org/resource/Neurocrine_Biosciences +
, https://global.dbpedia.org/id/4sMtC +
, http://yago-knowledge.org/resource/Neurocrine_Biosciences +
, http://www.wikidata.org/entity/Q7002174 +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1992 +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://www.wikidata.org/entity/Q43229 +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQBiotechnologyIndex +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInSanDiego%2CCalifornia +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
|
| rdfs:comment |
Neurocrine Biosciences, Inc. is an America … Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).treat adults with tardive dyskinesia (TD).
|
| rdfs:label |
Neurocrine Biosciences
|
